...
首页> 外文期刊>DMW: Deutsche Medizinische Wochenschrift >Evaluation of clinical trials following an approval from a research ethics committee
【24h】

Evaluation of clinical trials following an approval from a research ethics committee

机译:经研究伦理委员会批准后,对临床试验进行评估

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND AND OBJECTIVE: According to the Medical Association's professional code of conduct a consultation of the responsible ethics committee has to be undertaken prior to biomedical research. Up to date there has been no systematic analysis of published results after an approval from the research ethics committee of the Medical Association Westfalen-Lippe. A measure for the importance are publications of concluded trials. This work presents a comprehensive collection and evaluation of clinical trials that were approved in 1996. METHODS: Clinical trials that were approved by the ethics committee in the year 1996 were analysed concerning their publication parameters, if results have been reported to the ethics committee, the design of the study and their funding. Publications were found by database mining in the Internet sources "Pubmed" and "ISI Web of Knowledge". RESULTS: 70 % out of the 99 approved clinical trials were published as specified in the initial proposal, whereas in 2 % only aspects of the proposal were published. In 21 % of the cases only publications in closely related subjects could be identified. 7 % however remained unpublished. Of these studies 63 % were designed as mono centre study and 37 % as multi centre studies. The time from approval of the study until publication was 46 months (median value). Furthermore the analysis revealed, that 45 % of the studies were funded by industry. CONCLUSION: This work represents an unprecedented and detailed analysis of the clinical studies approved by a German ethics committee. In the course of this work a comprehensive catalogue with criteria to facilitate a collection and tracking mechanism was established. This should enable the ethics committee to comply with their new duties. A great amount of the clinical trials were presented in publications to the scientific community.
机译:背景与目的:根据医学协会的专业行为准则,在进行生物医学研究之前,必须先征求负责任的伦理委员会的意见。迄今为止,在获得Westfalen-Lippe医学协会研究伦理委员会的批准后,尚未对发表的结果进行系统的分析。重要性的衡量标准是结论试验的出版物。这项工作提供了1996年批准的临床试验的全面收集和评估。方法:如果伦理委员会已将结果报告给伦理委员会,则对伦理委员会在1996年批准的临床试验进行分析。研究的设计及其经费。通过数据库挖掘在Internet来源“ Pubmed”和“ ISI Web of Knowledge”中找到了出版物。结果:在99项批准的临床试验中,有70%的结果按初始方案的要求公开,而在2%的方案中,只有部分方案得到了发表。在21%的案例中,只能识别出与主题密切相关的出版物。但是,仍有7%未发布。在这些研究中,有63%被设计为单中心研究,而37%被设计为多中心研究。从研究批准到发表的时间为46个月(中值)。此外,分析显示,有45%的研究是由行业资助的。结论:这项工作代表了对德国伦理委员会批准的临床研究的前所未有的详细分析。在这项工作的过程中,建立了一个全面的目录,其中包含有助于收集和跟踪机制的标准。这应该使道德委员会能够履行其新职责。在出版物上向科学界介绍了大量的临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号